Voyager Therapeutics
Novartis puts up $1.7bn for Voyager’s gene therapy platform
Phil Taylor
gene therapy, neuroscience, Novartis, partnering, Voyager Therapeutics
0 Comment
X
Novartis puts up $1.7bn for Voyager’s gene therapy platform
https://pharmaphorum.com/news/novartis-puts-up-1-7bn-for-voyagers-gene-therapy-platform/
Biogen’s former R&D chief Al Sandrock resurfaces at Voyager
Phil Taylor
Biogen, R&D, senior management, Voyager Therapeutics
0 Comment
X
Biogen’s former R&D chief Al Sandrock resurfaces at Voyager
https://pharmaphorum.com/news/biogens-former-rd-chief-al-sandrock-resurfaces-at-voyager/
Sanofi hands back neurology gene therapy rights to Voyager
Richard Staines
Huntington's disease, neurology, R&D, Sanofi, Voyager Therapeutics
0 Comment
X
Sanofi hands back neurology gene therapy rights to Voyager
https://pharmaphorum.com/news/sanofi-hands-back-neurology-gene-therapy-rights-to-voyager/